Neurodevelopment vs. Neuromaintenance?
Our scientific aims are to:
- To determine whether there are critical periods during development when treatments are most effective and, if so, whether critical periods are treatment specific.
- To determine whether genetic convergence predicts convergence of phenotypic pathophysiology and ultimately common treatments. To meaningfully stratify autism spectrum disorders based on scientific criteria.
- To enable world-class innovative studies into the mechanisms that underlie autism.
- To prepare deep-phenotyped, trial ready cohorts for experimental medicine and clinical trials.